Adenovirally-mediated transfer of E2F-1 potentiates chemosensitivity of human glioma cells to temozolomide and BCNU
Candelaria Gomez‐Manzano(The University of Texas MD Anderson Cancer Center), Morris D. Groves(Texas Oncology), Min Hu(China Agricultural University), Juàn Fueyo(The University of Texas MD Anderson Cancer Center), Alfred Yung(The University of Texas MD Anderson Cancer Center), Ta-Jen Liu(The University of Texas MD Anderson Cancer Center), Michael G. Lemoine(The University of Texas MD Anderson Cancer Center), Ju He(The University of Texas MD Anderson Cancer Center), Paraskevi Mitlianga(The University of Texas MD Anderson Cancer Center)
Cited by 25
Related Papers
A map of human genome variation from population-scale sequencing
|Nature|2010|8.1k
Rindopepimut with temozolomide for patients with newly diagnosed, EGFRvIII-expressing glioblastoma (ACT IV): a randomised, double-blind, international phase 3 trial
|The Lancet Oncology|2017|1.1k
A super pan-genomic landscape of rice
|Cell Research|2022|381
The oncolytic virus Delta-24-RGD elicits an antitumor effect in pediatric glioma and DIPG mouse models
|Nature Communications|2019|146